机构：[1]Department of Traditional Chinese Medicine, The Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou 510150, China.[2]Department of Infection Disease, The Fifth Affiliated Hospital of Guangzhou Medical University Guangzhou, Guangzhou 510150, China.[3]School of Public Health, North China University of Science and Technology, Tangshan 063210, Hebei, China.[4]Department of Clinical Laboratory Medicine, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou 510150, China.[5]Department of Clinical Laboratory Medicine, The Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou 510150, China.[6]Departments of Geriatrics and Oncology, Guangzhou First People’s Hospital, Guangzhou 510180, China.[7]School of Medicine, South China University of Technology, Guangzhou, Guangdong, China.[8]The Third Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510378, Guangdong, China.[9]Department of Preventive Medicine, School of Public Health, Guangzhou Medical University, Guangzhou 510150, China.
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has spread to many countries around the world. In addition to lung disease, severe cases also displayed varying degrees of liver injury. This article will describe the latest developments regarding coronavirus and the pathogenesis of liver injury, the prone population and clinical characteristics of these patients, as well as providing some suggestions for clinical treatment.
基金：
This work was supported by the National Natural Science Foundation of China
(Grant No. 81803884) and the scientific research project of Guangdong Provincial
Bureau of traditional Chinese Medicine (20191215).
语种：
外文
PubmedID：
中科院(CAS)分区：
出版当年[2020]版：
大类|3 区医学
小类|4 区病毒学
最新[2025]版：
大类|3 区医学
小类|3 区病毒学
第一作者：
第一作者机构：[1]Department of Traditional Chinese Medicine, The Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou 510150, China.
共同第一作者：
通讯作者：
推荐引用方式(GB/T 7714)：
Dongdong Yu,Qingru Du,Shengguang Yan,et al.Liver injury in COVID-19: clinical features and treatment management.[J].Virology journal.2021,18(1):121.doi:10.1186/s12985-021-01593-1.
APA：
Dongdong Yu,Qingru Du,Shengguang Yan,Xu‑Guang Guo,Yehao He...&Shi Ouyang.(2021).Liver injury in COVID-19: clinical features and treatment management..Virology journal,18,(1)
MLA：
Dongdong Yu,et al."Liver injury in COVID-19: clinical features and treatment management.".Virology journal 18..1(2021):121
